Volatile hydrocarbons in pharmaceutical solutions.
Volatile pollutants such as hydrocarbons have, during many years, been analysed in small concentrations in air, water, food, pharmaceutical solutions, and human blood and tissues. It has also been shown that such substances have unexpected consequences for cell cultures and scientific experiments. These substances also accumulate in patients receiving haemodialysis and these patients are exposed to quite high concentrations. The knowledge of the toxicity of such compounds has led to the development of maximum limit concentrations with the aim to decrease the exposure of humans. This paper discusses the problems of human exposure in general and especially through pharmaceutical solutions, and the possibilities of eliminating such compounds with the aim of decreasing the exposure as a hygienic challenge.
Kroneld
R
R
Department of Medicine, University of Turku, Finland.
D005387:Finland; D015312:Hemodialysis Solutions / Q000032:analysis; D006838:Hydrocarbons / Q000032:analysis*; D012996:Solutions / Q000032:analysis* / Q000592:standards; D014873:Water Pollutants / Q000032:analysis* / Q000592:standards; D014876:Water Pollution / Q000517:prevention & control*
D015312:Hemodialysis Solutions; D006838:Hydrocarbons; D012996:Solutions; D014873:Water Pollutants